Cargando…
Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
Autor principal: | Reiffel, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252818/ https://www.ncbi.nlm.nih.gov/pubmed/32494423 http://dx.doi.org/10.19102/icrm.2019.100803 |
Ejemplares similares
-
“Ranolaziodarone”—A Synergism You Should Not Miss
por: Reiffel, James A.
Publicado: (2021) -
Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018) -
Ebola Virus Infection: What Should Be Known?
por: Wiwanitkit, Viroj
Publicado: (2014) -
Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient
por: Reiffel, James A.
Publicado: (2019) -
COVID-19: What Should Clinicians and Scientists Do and When?
por: Corley, Douglas A., et al.
Publicado: (2020)